Yahoo MoviesBiden unveils $1.9T COVID-19 relief package
Yahoo Finance's Rick Newman joined Yahoo Finance Live to break down Biden's $1.9T COVID-19 relief package and what this would mean for Americans in the coming months.
Yahoo Finance's Rick Newman joined Yahoo Finance Live to break down Biden's $1.9T COVID-19 relief package and what this would mean for Americans in the coming months.
ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (NASDAQ: ANIP) today announced business highlights and financial results for the three and 12 months ended December 31, 2020.
LOS ANGELES, March 09, 2021 (GLOBE NEWSWIRE) -- Reliance Steel & Aluminum Co. (NYSE: RS) announced today that James Hoffman, Chief Executive Officer, Karla Lewis, President, and Arthur Ajemyan, Vice President and Chief Financial Officer, will participate in the J.P. Morgan 2021 Industrials Conference on Tuesday, March 16, 2021. Reliance is scheduled to present virtually at 5:20 p.m. ET and will participate in virtual meetings with investors throughout the day. The presentation will be webcast live over the Internet, hosted on the Investors section of the Company's website at investor.rsac.com. In addition to the live webcast, a replay will be available on the Company’s website for 90 days following the event. About Reliance Steel & Aluminum Co. Founded in 1939 and headquartered in Los Angeles, California, Reliance Steel & Aluminum Co. (NYSE: RS) is a leading global diversified metal solutions provider and the largest metals service center company in North America. Through a network of approximately 300 locations in 40 states and 13 countries outside of the United States, Reliance provides value-added metals processing services and distributes a full line of over 100,000 metal products to more than 125,000 customers in a broad range of industries. Reliance focuses on small orders with quick turnaround and increasing levels of value-added processing. In 2020, Reliance’s average order size was $1,910, approximately 49% of orders included value-added processing and approximately 40% of orders were delivered within 24 hours. Reliance Steel & Aluminum Co.’s press releases and additional information are available on the Company’s website at www.rsac.com. CONTACT: (213) 576-2428 investor@rsac.com or Addo Investor Relations (310) 829-5400
Ra Medical Systems, Inc. (NYSE: RMED) announces that it will report 2020 fourth quarter and full year financial results and provide a business update after market close on Tuesday, March 16, 2021. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide a company update.
The "Meat Products Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering.
Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 8. - Influencer Pool: 1253. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.New York, March 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vertebroplasty Industry" - https://www.reportlinker.com/p06033232/?utm_source=GNW In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack. - Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations. Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations. Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives. Abstract: - Global Vertebroplasty Market to Reach $301.7 Million by 2027 - Amid the COVID-19 crisis, the global market for Vertebroplasty estimated at US$211 Million in the year 2020, is projected to reach a revised size of US$301.7 Million by 2027, growing at a CAGR of 5.2% over the period 2020-2027. - The U.S. Market is Estimated at $57.2 Million, While China is Forecast to Grow at 8% CAGR - The Vertebroplasty market in the U.S. is estimated at US$57.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$62.5 Million by the year 2027 trailing a CAGR of 8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 4.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR. Select Competitors (Total 42 Featured) - Alphatec Spine, Inc.DePuy Synthes (Johnson & Johnson)Globus Medical, Inc.IZI Medial ProductsMedtronicMerit Medical Systems, Inc.RontisSPINUS (BMK Global Medical Company)Stryker CorporationZavation Read the full report: https://www.reportlinker.com/p06033232/?utm_source=GNW I. METHODOLOGYII. EXECUTIVE SUMMARY1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of Covid-19 and a Looming Global Recession Global Competitor Market Shares Vertebroplasty Competitor Market Share Scenario Worldwide (in %): 2020E Global Competitor Market Shares by Segment 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Vertebroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 2: World Historic Review for Vertebroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 3: World 15-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 III. MARKET ANALYSISUNITED STATES Market Facts & Figures Market Analytics Table 4: USA Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 5: USA Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR CANADA Table 6: Canada Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 7: Canada Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR JAPAN Table 8: Japan Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 9: Japan Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR CHINA Table 10: China Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 11: China Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR EUROPE Market Facts & Figures Market Analytics Table 12: Europe Current & Future Analysis for Vertebroplasty by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 13: Europe Historic Review for Vertebroplasty by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 14: Europe 15-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 FRANCE Table 15: France Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 16: France Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR GERMANY Table 17: Germany Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 18: Germany Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR ITALY Table 19: Italy Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 20: Italy Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR UNITED KINGDOM Table 21: UK Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 22: UK Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR SPAIN Table 23: Spain Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 24: Spain Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR RUSSIA Table 25: Russia Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 26: Russia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR REST OF EUROPE Table 27: Rest of Europe Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 28: Rest of Europe Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR ASIA-PACIFIC Table 29: Asia-Pacific Current & Future Analysis for Vertebroplasty by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 30: Asia-Pacific Historic Review for Vertebroplasty by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 31: Asia-Pacific 15-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 AUSTRALIA Table 32: Australia Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 33: Australia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR INDIA Table 34: India Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 35: India Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR SOUTH KOREA Table 36: South Korea Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 37: South Korea Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR REST OF ASIA-PACIFIC Table 38: Rest of Asia-Pacific Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 39: Rest of Asia-Pacific Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR LATIN AMERICA Table 40: Latin America Current & Future Analysis for Vertebroplasty by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 41: Latin America Historic Review for Vertebroplasty by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 42: Latin America 15-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027 ARGENTINA Table 43: Argentina Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 44: Argentina Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR BRAZIL Table 45: Brazil Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 46: Brazil Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR MEXICO Table 47: Mexico Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 48: Mexico Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR REST OF LATIN AMERICA Table 49: Rest of Latin America Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 50: Rest of Latin America Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR MIDDLE EAST Table 51: Middle East Current & Future Analysis for Vertebroplasty by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 52: Middle East Historic Review for Vertebroplasty by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 53: Middle East 15-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027 IRAN Table 54: Iran Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 55: Iran Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR ISRAEL Table 56: Israel Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 57: Israel Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR SAUDI ARABIA Table 58: Saudi Arabia Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 59: Saudi Arabia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR UNITED ARAB EMIRATES Table 60: UAE Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 61: UAE Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR REST OF MIDDLE EAST Table 62: Rest of Middle East Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 63: Rest of Middle East Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR AFRICA Table 64: Africa Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 65: Africa Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR IV. COMPETITIONTotal Companies Profiled: 42Read the full report: https://www.reportlinker.com/p06033232/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
Mavis Bran claimed her husband burned her with scalding oil at their chip shop before she died in October 2018.
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary Clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeSCAPA GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure08 MARCH 2021(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”N/A 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: ORDINARY 5p InterestsShort positionsNumber%Number%(1) Relevant securities owned and/or controlled:2,789,0631.4846 (2) Cash-settled derivatives: (3) Stock-settled derivatives (including options) and agreements to purchase/sell: TOTAL:2,789,0631.4846 All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors’ and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant securityPurchase/sale Number of securitiesPrice per unitORDINARY 5pSALE2,650212p (b) Cash-settled derivative transactions Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unitNONE (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unitNONE (ii) Exercise Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)NONE 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” NONE (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none” NONE (c) Attachments Is a Supplemental Form 8 (Open Positions) attached?NO Date of disclosure:09 MARCH 2021Contact name:MARK ELLIOTTTelephone number:01253 376539 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
Dublin, March 09, 2021 (GLOBE NEWSWIRE) -- The "Pest Control Service Market Size, Share & Trends Analysis Report by Application (Residential, Commercial), by End Use (Insect, Termite), by Region, and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering. The global pest control service market size is anticipated to reach USD 28.1 billion by 2027, expanding at a CAGR of 4.5% from 2020 to 2027. Changing climate and a rise in temperature are acting as major catalysts for the rising demand for pest control services. Other factors such as increasing commercial and residential projects and intolerance for pests are fueling the market growth.Moreover, the increasing popularity of the usage of biocides is supporting market growth. Factors such as environmental friendly nature and replacement for traditional pesticides are increasing the product demand. For instance, Rentokil has registered CO2 for use in the control of rodents under EU biocidal regulations. The company is continuing to work in the areas of insect and rodent control.Companies in the market are focusing on strategies, such as mergers and acquisitions, in order to gain market share and increase their service footprint. For instance, as per The Potomac Company, in 2018, Rentokil, ServiceMaster, and Rollins have spent USD 359, 254, and 77 million, respectively on pest control acquisition. In 2019, Rentokil Initial PLC had carried out 41 acquisitions in 23 countries. The company had acquired 30 pest control, 8 hygiene, and 3 Ambius businesses, generating annualized revenues in the year prior to purchase of USD 155.2 million (Euro 137 million). The company has carried acquisitions in Australia, Brazil, Canada, Chile, Colombia, Costa Rica, Dominican Republic, Dutch Antilles, Finland, France, Greece, Indonesia, Malaysia, Peru, Poland, Spain, Tanzania, Thailand, the U.K., and the U.S. Moreover, the company has entered new markets of Jordan, Sri Lanka, and Uruguay.In terms of application, the commercial segment is estimated to expand at the fastest CAGR from 2020 to 2027. The growing commercial sector, coupled with strict rules and regulations, is acting as a major factor for the segment growth. Moreover, businesses have a multiyear contract with the service providers, leading to continuous revenue generation for the contract holding companies.The insect segment dominated the market with a revenue-based share of 42.0% in 2019. As per a research conducted by the National Pest Management Association (NPMA), in 2018, 97% of the pest professionals have treated bed bugs, 69% of them said that the overall bed bug service was effective, and 66% said that the demand for these services is increasing. Moreover, 89% of pest professionals encountered bed bugs in apartments/condominiums, 68% in hotels/motels, 59% in nursing homes, 46% in office buildings, 45% in college dorms, and 36% in hospitals.North America dominated the market with a revenue-based share of 48.3% in 2019. As per a report published by Rentokil, in 2018, 29% of all Americans have, at some point experienced a rodent pest issue, 35% in the Northeast. Moreover, 80% of U.S. hotels and motels reported some presence of bed bugs in the past year. Yellow fever mosquito is now found in 23 U.S. states - West Nile, Dengue, and Chikungunya viruses are now present in the U.S.Pest Control Service Market Report Highlights The commercial application segment is expected to witness the fastest growth from 2020 to 2027.The insect end-use segment was valued at USD 8.3 billion in 2019.Asia Pacific is expected to witness the fastest growth over the forecast period with a revenue-based CAGR of 5.3% from 2020 to 2027. Key Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive SummaryChapter 3. Pest Control Service Market Variables, Trends & Scope3.1. Market Introduction3.2. Penetration & Growth Prospect Mapping3.3. Industry Value Chain Analysis3.3.1. Sales/Retail Channel Analysis3.3.2. Profit Margin Analysis3.4. Market Dynamics3.4.1. Market Driver Analysis3.4.2. Market Restraint Analysis3.4.3. Industry Challenges3.4.4. Industry Opportunities3.5. Business Environment Analysis3.5.1. Industry Analysis-Porter's3.6. Roadmap of Pest Control Service Market3.7. Market Entry StrategiesChapter 4. Consumer Behaviour Analysis4.1. Consumer Trends and Preferences4.2. Factors Affecting Buying Decision4.3. Consumer Application Adoption4.4. Observations & RecommendationsChapter 5. Pest Control Service Market: Application Estimates & Trend Analysis5.1. Application Movement Analysis & Market Share, 2019 & 20275.2. Residential5.3. CommercialChapter 6. Pest Control Service Market: End Use Estimates & Trend Analysis6.1. End Use Movement Analysis & Market Share, 2019 & 20276.2. Insect6.3. Rodents6.4. Termite6.5. Mosquito6.6. OthersChapter 7. Pest Control Service Market: Regional Estimates & Trend Analysis7.1. Regional Movement Analysis & Market Share, 2019 & 2027Chapter 8. Competitive Analysis8.1. Key global players, recent developments & their impact on the industry8.2. Key Company/Competition Categorization (Key innovators, Market leaders, Emerging players)8.3. Vendor Landscape8.3.1. Key company market share analysis, 2019Chapter 9. Company Profiles9.1. Company Overview9.2. Financial Performance9.3. Application Benchmarking9.4. Strategic Initiatives Rentokil Initial PLCRollins, Inc.ServiceMaster Global Holdings, Inc.Anticimex GroupArrow Exterminators Inc.Asante Inc.Dodson Pest Control IncEcolabMassey Services Inc.SANIX INC. For more information about this report visit https://www.researchandmarkets.com/r/7awear CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Hege Riise to be named Team GB football coach for Tokyo OlympicsNorwegian took over as England coach after Neville exitRiise has won Olympic gold as player and US assistant Hege Riise addresses the England players before the game against Northern Ireland. Photograph: Lynne Cameron - The FA/The FA/Getty Images
“Dissemination of false information attacking women” is very much a reality in India.
Goldman Sachs just made two very bold calls in the tech space.
WisdomTree Issuer plc – Daily Fund Prices 08-March-21 WisdomTree Artificial Intelligence UCITS ETF - USD Acc08/03/2021IE00BDVPNG137423541USD424,900,740.5857.2369WisdomTree AT1 CoCo Bond UCITS ETF – USD08/03/2021IE00BZ0XVF52513029USD52,890,850.54103.0952WisdomTree AT1 CoCo Bond UCITS ETF – EUR Hedged08/03/2021IE00BFNNN236314036EUR32,372,938.42103.0867WisdomTree AT1 CoCo Bond UCITS ETF – GBP Hedged08/03/2021IE00BFNNN45934640GBP3,619,361.00104.485WisdomTree AT1 CoCo Bond UCITS ETF – USD Acc08/03/2021IE00BZ0XVG6942463USD5,076,764.20119.5574WisdomTree AT1 CoCo Bond UCITS ETF – USD Hedged08/03/2021IE00BFNNN01217006USD1,866,564.25109.7592WisdomTree Battery Solutions UCITS ETF - USD Acc08/03/2021IE00BKLF1R758073534USD346,372,573.8142.9022WisdomTree Cloud Computing UCITS ETF - USD Acc08/03/2021IE00BJGWQN7212921000USD589,187,686.6245.5992WisdomTree Cybersecurity UCITS ETF - USD Acc08/03/2021IE00BLPK3577400000USD8,123,904.4520.3098WisdomTree Emerging Markets Equity Income UCITS ETF08/03/2021IE00BQQ3Q0672637109USD40,150,081.7915.225WisdomTree Emerging Markets Equity Income UCITS ETF Acc08/03/2021IE00BDF12W4990558USD1,960,038.0821.644WisdomTree Emerging Markets Small Cap Dividend UCITS ETF08/03/2021IE00BQZJBM261630000USD30,266,653.8918.5685WisdomTree Enhanced Commodity UCITS ETF – CHF Hedged Acc08/03/2021IE00BG88WL21210000CHF2,315,593.7611.0266WisdomTree Enhanced Commodity UCITS ETF – EUR Hedged Acc08/03/2021IE00BG88WG772725000EUR28,032,926.4810.2873WisdomTree Enhanced Commodity UCITS ETF – GBP Hedged Acc08/03/2021IE00BG88WH841250000GBP13,098,623.1610.4789WisdomTree Enhanced Commodity UCITS ETF - USD08/03/2021IE00BZ1GHD37775000USD8,645,010.2911.1549WisdomTree Enhanced Commodity UCITS ETF - USD Acc08/03/2021IE00BYMLZY7410400000USD120,766,381.7611.6122WisdomTree EUR Aggregate Bond Enhanced Yield UCITS ETF – EUR08/03/2021IE00BD49R912173389EUR9,443,351.4454.4634WisdomTree EUR Aggregate Bond Enhanced Yield UCITS ETF – EUR Acc08/03/2021IE00BD49RB3969498EUR3,873,288.9255.7324WisdomTree EUR Government Bond Enhanced Yield UCITS ETF08/03/2021IE00BD49RJ1512743EUR705,084.5555.3311WisdomTree EUR Government Bond Enhanced Yield UCITS ETF – EUR Acc08/03/2021IE00BD49RK2047000EUR2,661,631.4856.6305WisdomTree Europe Equity Income UCITS ETF08/03/2021IE00BQZJBX311732717EUR19,501,273.2811.2547WisdomTree Europe Equity Income UCITS ETF Acc08/03/2021IE00BDF16007352386EUR5,021,918.8214.2512WisdomTree Europe Equity UCITS ETF - CHF Hedged Acc08/03/2021IE00BYQCZT117703CHF139,453.2818.1038WisdomTree Europe Equity UCITS ETF - EUR Acc08/03/2021IE00BYQCZX56269545EUR4,976,515.0418.4627WisdomTree Europe Equity UCITS ETF - GBP Hedged08/03/2021IE00BYQCZQ89131454GBP1,521,143.2211.5717WisdomTree Europe Equity UCITS ETF - USD Hedged08/03/2021IE00BVXBH1631135423USD21,818,380.1519.2161WisdomTree Europe Equity UCITS ETF - USD Hedged Acc08/03/2021IE00BYQCZP721988673USD45,061,679.1822.6592WisdomTree Europe Small Cap Dividend UCITS ETF08/03/2021IE00BQZJC5271607964EUR29,236,171.9718.1821WisdomTree Europe Small Cap Dividend UCITS ETF Acc08/03/2021IE00BDF16114263593EUR4,438,113.0216.837WisdomTree European Union Bond UCITS ETF - EUR Acc08/03/2021IE00BMXWRM76155000EUR15,121,305.2397.5568WisdomTree Eurozone Quality Dividend Growth UCITS ETF - EUR08/03/2021IE00BZ56SY76547208EUR9,652,294.3617.6392WisdomTree Eurozone Quality Dividend Growth UCITS ETF - EUR Acc08/03/2021IE00BZ56TQ67679042EUR13,706,317.5320.1848WisdomTree Global Quality Dividend Growth UCITS ETF - USD08/03/2021IE00BZ56RN96308660USD8,494,568.5527.5208WisdomTree Global Quality Dividend Growth UCITS ETF - USD Acc08/03/2021IE00BZ56SW522000284USD59,790,687.8429.8911WisdomTree Japan Equity UCITS ETF - CHF Hedged Acc08/03/2021IE00BYQCZL35235650CHF4,802,704.8920.3807WisdomTree Japan Equity UCITS ETF - EUR Hedged Acc08/03/2021IE00BYQCZJ13201551EUR3,515,772.4217.4436WisdomTree Japan Equity UCITS ETF - GBP Hedged08/03/2021IE00BYQCZF7489539GBP1,003,525.5811.2077WisdomTree Japan Equity UCITS ETF - JPY Acc08/03/2021IE00BYQCZN58189960USD4,210,582.3922.1656WisdomTree Japan Equity UCITS ETF - USD Hedged08/03/2021IE00BVXC48541231738USD21,856,514.0717.7445WisdomTree Japan Equity UCITS ETF - USD Hedged Acc08/03/2021IE00BYQCZD50400818USD8,159,836.4120.358WisdomTree UK Equity Income UCITS ETF08/03/2021IE00BYPGTJ261800000GBP7,681,883.974.2677WisdomTree US Equity Income UCITS ETF08/03/2021IE00BQZJBQ63804894USD16,144,298.5020.0577WisdomTree US Equity Income UCITS ETF - EUR Hedged Acc08/03/2021IE00BD6RZW238073EUR142,491.0617.6503WisdomTree US Equity Income UCITS ETF - GBP Hedged Acc08/03/2021IE00BD6RZZ53379189GBP6,014,120.6715.8605WisdomTree US Equity Income UCITS ETF Acc08/03/2021IE00BD6RZT931181920USD25,292,658.9121.3996WisdomTree US Quality Dividend Growth UCITS ETF - USD08/03/2021IE00BZ56RD98266031USD7,460,662.8228.0443WisdomTree US Quality Dividend Growth UCITS ETF - USD Acc08/03/2021IE00BZ56RG202054651USD62,111,939.3130.2299WisdomTree USD Floating Rate Treasury Bond UCITS ETF - USD08/03/2021IE00BJFN5P6320916USD1,048,853.0750.146WisdomTree USD Floating Rate Treasury Bond UCITS ETF - USD Acc08/03/2021IE00BJJYYX67378822USD19,316,685.8950.9915
Pirates' stellar win offers lessons for Eddie Jones and English rugbyThe national coach says the Championship is ‘something I don’t really worry about’, but the state of a league that helps to shape tomorrow’s stars should be a concern Luke Scully celebrates with his Cornish Pirates teammates after their famous victory against Saracens in the Championship. Photograph: Matt Impey/Shutterstock
PRINCETON, N.J., March 09, 2021 (GLOBE NEWSWIRE) -- Clearway Energy Operating LLC (“Clearway Operating”), a subsidiary of Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) (“Clearway Energy”), announced the expiration and results of its previously announced cash tender offer (the “Tender Offer”) to purchase any and all of its outstanding 5.750% senior notes due 2025 (the “2025 Notes”). The Tender Offer expired at 5:00 p.m., New York City time, on March 8, 2021 (the “Expiration Time”). As of the Expiration Time, an aggregate principal amount of $411,334,000, or 68.6%, of the 2025 Notes were validly tendered and not validly withdrawn, which amount excludes $6,925,000 aggregate principal amount of the Notes that remain subject to guaranteed delivery procedures. Clearway Operating has accepted for payment all 2025 Notes validly tendered prior to the Expiration Time pursuant to the Tender Offer and expects to make payment for such 2025 Notes on March 9, 2021. Clearway Operating also expects to accept for payment all 2025 Notes that remain subject to guaranteed delivery procedures and to make payment for such 2025 Notes on March 11, 2021. Concurrently with the launch of the tender offer, Clearway Operating exercised its right to optionally redeem any 2025 Notes not validly tendered and purchased in the tender offer, pursuant to the terms of the indenture governing the 2025 Notes, which redemption will occur on March 17, 2021. Requests for documents relating to the tender offer may be directed to D.F. King & Co., Inc., the Information Agent, at (866) 796-6867 (Toll-Free) or (212) 269-5550, by email at cwen@dfking.com, or via the following web address: www.dfking.com/cwen. Morgan Stanley & Co. LLC acted as the Dealer Manager for the tender offer. Questions regarding the tender offer may be directed to the Dealer Manager at +1 (800) 624-1808 (Toll-Free) or +1 (212) 761-1057 (Collect). This press release is for informational purposes only and does not constitute a notice of redemption under the optional redemption provisions of the indenture governing the 2025 Notes, nor does it constitute an offer to sell, or a solicitation of an offer to buy, any security, including the New Notes, nor does it constitute a solicitation for an offer to purchase any security, including the New Notes or the 2025 Notes, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offering, solicitation or sale would be unlawful. About Clearway Energy, Inc. Clearway Energy, Inc. is one of the largest renewable energy owners in the US with over 4,200 net MW of installed wind and solar generation projects. Clearway Energy also owns approximately 2,500 net MW of environmentally-sound, highly efficient natural gas generation facilities as well as a portfolio of district energy systems. Through this environmentally-sound diversified and primarily contracted portfolio, Clearway Energy endeavors to provide its investors with stable and growing dividend income. Clearway Energy’s Class C and Class A common stock are traded on the New York Stock Exchange under the symbols CWEN and CWEN.A, respectively. Clearway Energy, Inc. is sponsored by its controlling investor Global Infrastructure Partners III (GIP), an independent infrastructure fund manager that invests in infrastructure and businesses in both OECD and select emerging market countries, through GIP’s portfolio company, Clearway Energy Group. Forward-Looking Statements This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are subject to certain risks, uncertainties and assumptions and typically can be identified by the use of words such as “expect,” “estimate,” “should,” “anticipate,” “forecast,” “plan,” “outlook,” “believe” and similar terms. Although Clearway Energy believes that the expectations are reasonable, it can give no assurance that these expectations will prove to be correct, and actual results may vary materially. Factors that could cause actual results to differ materially from those contemplated above include, among others, impacts related to COVID-19 or any other pandemic, impacts of recent weather events on the Company, its operations, its facilities and its financial results, risks and uncertainties related to the capital markets generally, whether Clearway Energy will consummate the offering, the anticipated terms of the New Notes and the anticipated use of proceeds, including the results of the tender offer. Clearway Energy undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. The foregoing review of factors that could cause Clearway Energy’s actual results to differ materially from those contemplated in the forward-looking statements included in this news release should be considered in connection with information regarding risks and uncertainties that may affect Clearway Energy’s future results included in Clearway Energy’s filings, or the filings of Clearway Energy LLC, with the Securities and Exchange Commission at www.sec.gov. In addition, Clearway Energy makes available free of charge at www.clearwayenergy.com, copies of materials it files with, or furnishes to, the Securities Exchange Commission. CONTACT: Investors: Akil Marsh, 609-608-1500 investor.relations@clearwayenergy.com Media: Zadie Oleksiw, 202-836-5754 media@clearwayenergy.com
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary Clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeIDOX PLC (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:DYE & DURHAM LIMITED AS AN ASSOCIATE OF THE CANACCORD GENUITY GROUP (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure08 MARCH 2021(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”N/A 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: ORDINARY 1p InterestsShort positionsNumber%Number%(1) Relevant securities owned and/or controlled:33,623,9817.5783 (2) Cash-settled derivatives: (3) Stock-settled derivatives (including options) and agreements to purchase/sell: TOTAL:33,623,9817.5783 All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors’ and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant securityPurchase/sale Number of securitiesPrice per unitORDINARY 1pSALE2,25571.8pORDINARY 1pSALE50072p (b) Cash-settled derivative transactions Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unitNONE (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unitNONE (ii) Exercise Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)NONE 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” NONE (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none” NONE (c) Attachments Is a Supplemental Form 8 (Open Positions) attached?NO Date of disclosure:09 MARCH 2021Contact name:MARK ELLIOTTTelephone number:01253 376539 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced a corporate update in conjunction with its presentation at the H.C. Wainwright Global Life Sciences Conference. David McNally, President, CEO and Chairman of Titan Medical, will provide an overview of the Company and its Enos™ robotic single access surgical system at the conference, which is available for on-demand access on Titan Medical’s website under the "Investors" section.
ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced that it has signed a definitive agreement to acquire Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities for $163.5 million, including $89.5 million in cash and $74 million in equity plus two potential future cash earn-outs of up to $46.5 million. The transaction has been approved by the ANI Board of Directors and is expected to close in the second half of 2021, subject to regulatory approvals and approval by ANI shareholders as required by Nasdaq listing standards as described below. Equity holders of Novitium have approved the transaction.
WATERLOO, Ontario, March 09, 2021 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Ontario-based Universal Logistics Inc., a freight forwarding and customs brokerage services provider, is using the Descartes Canadian Customs Brokerage™ solution to increase customer satisfaction and improve operational effectiveness through automation of labor-intensive customs declarations processes. The solution is enhanced by an innovative documentation digitization solution from Windmill, a Descartes United by Design partner. “Best-in-class technology is an investment we make to help our people provide customers with smarter logistics solutions,” said Paul Glionna, Vice President Systems Development & Operations at Universal Logistics. “Using the Descartes system, we’ve achieved a level of automation that has unlocked significant productive time for higher quality customer conversations. Multi-page commercial invoices that previously took hours to complete are now done in 10 minutes, and commodities are now classified at the time an entry is created to further streamline customs clearance. This type of process automation is a high impact, low effort means to allow us to focus on higher-value work for our customers.” An on-demand software solution, Descartes Canadian Customs Brokerage provides customs brokers with the ability to streamline and automate the workflows associated with customs entries, regulatory filings, and customer invoicing to improve operational productivity. The solution uses the Descartes Global Logistics Network™ (Descartes GLN™) to electronically connect customs brokers with shippers, carriers and regulatory authorities around the world to speed data collection and dissemination. Descartes Canadian Customs Brokerage is integrated with Windmill’s EasyClearance solution to allow unstructured electronic documents, such as PDFs of commercial invoices from shippers, to be converted quickly and effectively to structured data, eliminating the need for repetitive, error-prone, time-consuming manual data entry that would slow the customs clearance process. “Leading customs brokers such as Universal Logistics are using automation to minimize their effort in lower value tasks and give them more time to focus on customer service,” said Glenn Palanacki, VP Industry Strategy, Forwarding and Brokerage at Descartes. “Given our long-standing commitment to being at the technology forefront for customs brokers, we’re happy to work with Windmill to make significant advances in the automation to improve the efficiency and effectiveness of Canada Border Service Agency (CBSA) filing processes.” About Universal Logistics Inc. Based in Thornhill, Ontario, Universal Logistics Inc. offers a complete package of international ocean and air freight, trucking, customs brokerage, warehousing and distribution services on both sides of the border between Canada and the U.S. to help customers reduce freight costs, optimize transit times and achieve air-tight compliance. Universal prides itself on our commitment to provide innovative logistics solutions while honoring the family values and client focus established by our founder, Frank Glionna Sr., when he started the business in 1949. For more information, visit www.universallogistics.ca. About Windmill Information technology provider Windmill is a leader in cognitive capture, business process automation, robotics process automation and business intelligence for different industries, including transportation and logistics, insurance and banking among others. Windmill has been awarded with the highest recognition by its partners in Canada, USA, Latin America and the Caribbean. For more information, visit www.windmill.services. About Descartes Descartes (Nasdaq:DSGX) (TSX:DSG) is the global leader in providing on-demand, software-as-a-service solutions focused on improving the productivity, performance and security of logistics-intensive businesses. Customers use our modular, software-as-a-service solutions to route, schedule, track and measure delivery resources; plan, allocate and execute shipments; rate, audit and pay transportation invoices; access global trade data; file customs and security documents for imports and exports; and complete numerous other logistics processes by participating in the world's largest, collaborative multimodal logistics community. Our headquarters are in Waterloo, Ontario, Canada and we have offices and partners around the world. Learn more at www.descartes.com, and connect with us on LinkedIn and Twitter. Global Media Contact Cara StrohackTel: +1(800) 419-8495 ext. 202025 cstrohack@descartes.com Cautionary Statement Regarding Forward-Looking Statements This release contains forward-looking information within the meaning of applicable securities laws ("forward-looking statements") that relate to Descartes' solution offering and potential benefits derived therefrom; and other matters. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements to differ materially from the anticipated results, performance or achievements or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the factors and assumptions discussed in the section entitled, "Certain Factors That May Affect Future Results" in documents filed with the Securities and Exchange Commission, the Ontario Securities Commission and other securities commissions across Canada including Descartes most recently filed management's discussion and analysis. If any such risks actually occur, they could materially adversely affect our business, financial condition or results of operations. In that case, the trading price of our common shares could decline, perhaps materially. Readers are cautioned not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Forward-looking statements are provided for the purposes of providing information about management's current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes. We do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
TELUS International (NYSE and TSX: TIXT), a leading digital customer experience (CX) innovator that designs, builds and delivers next-generation solutions for global and disruptive brands, today announced the appointment of Maria Pardee as the company’s new chief commercial officer (CCO).
Figure 1.0 Plan View – Target A, B and E - Candelones Extension Deposit Figure 2.0 Section Looking NW – Target A, B and E - Candelones Extension Deposit LP20-167 intersected 12.0 meters averaging 5.9 g/t Au and 18.0 g/t Ag in a new zone of mineralization east and stratigraphically above Target A;LP20-167 intersected anomalous disseminated mineralization over 328 meters, averaging 1.2 g/t Au;LP20-169 intersected a new zone of blind oxide mineralization just below the collar at surface, returning 14.0m @ 2.11 g/t Au.LP20-169 intersected two broad zones of mineralization, the first extending from surface to 154 meters averaging 0.58 g/t Au and a second, deeper interval of 43 meters averaging 0.76 g/t Au;All mineralized intervals lie outside the current mineral resource optimization limit;Both holes intersected Target A as planned with LP20-167 returning 33.0m @ 4.89 g/t Au with 0.4% Cu and LP20-169 reporting 26.0m averaging 0.97 g/t Au with 0.11% Cu;Both holes will be extended to intersect Target B at depth. TORONTO, March 09, 2021 (GLOBE NEWSWIRE) -- Unigold Inc. (“Unigold” or the “Company”) (TSX-V:UGD; OTCQX: UGDIF; FSE:UGB1) is pleased to report recent drill results from its 100% owned Neita concession in the Dominican Republic. Joseph Hamilton, Chairman and CEO of Unigold notes: “The latest results substantiate our belief that there continues to be exceptional discovery potential within the immediate Candelones area. This new zone (“E”), sub-crops to within 2.0 meters of surface, persists over 150 meters downhole and is open in all directions. This was a blind discovery, similar in all aspect to Targets A, B and C of the Candelones Extension. The only surficial evidence in the area originates from scattered rock geochemistry samples returning +1.0 g/ Au, largely mapped as float samples collected downslope from the Candelones Extension ridgeline. These latest holes, along with the previously reported LP20-165, were drilled along a SW alignment, to evaluate interpreted structural offsets. This SW alignment also allowed us to intersect Target B at depth, well below the 2013 resource limit, something that wasn’t possible with a NW drill alignment due to drill access challenges. The discovery of Target E suggests potential to continue to expand the resource footprint to the east, especially considering the mineralization sub-crops to within 2.0 meters of surface and extends for over 100 meters. We have decided to dedicate a diamond drill to this recent discovery and are planning step out holes to evaluate the near surface Target E discovery. Our other drills remain active at Target B and C following our current program of probing the depth extent of these two high-grade zones.” Table 1 summarizes the results reported herein (Ref. Figure 1.0 and 2.0). Table 1.0 – Summary Results TargetHole (#)From(m)To (m)Interval(m) (1)Au (g/t)Ag (g/t)Cu (%)Zn (%)ELP20-167 (2)142.00470.00328.001.202.300.120.13 including142.00229.0087.001.586.210.040.41 including185.00197.0012.005.8918.000.060.87Aand292.00378.0086.002.651.790.300.00 including323.00356.0033.004.892.560.400.00 including339.00350.0011.005.963.070.500.00ELP20-169 (3)2.00156.00154.000.581.950.110.14 including OXIDE2.0016.0014.002.118.200.080.10 including OXIDE4.0011.007.003.7414.500.110.12Aand333.00376.0043.000.761.140.130.04 including340.00366.0026.000.971.290.110.06 (1)Interval represents drilled length in meters and not true width.(2)Drilled interval reported includes 44.0m of barren dike material, the grade of which has been assumed to be 0.00 for all metals.(3)Drilled interval reported includes 10.0m of barren dike material, the grade of which has been assumed to be 0.00 for all metals. Holes LP20-167, LP20-169 and LP20-165 (previously reported in PR 2021-03), were drilled as a fence of holes in a SW direction, perpendicular to the dominant NW drill orientation. This alignment roughly parallels the andesite-dacite contact which is interpreted to control the low-grade mineralization halo. The holes were designed to test interpreted high-angle northwest to northeast trending fault zones that disrupt the high grade mineralization at both Targets A and B while providing intersections of both Target A and Target B. All three holes intersected evidence of faulting (Ref. Figure 2.0) which is currently being assessed prior to positioning follow-up drill holes. LP20-167 intersected 12.0 meters averaging 5.89 g/t Au, 18.0 g/t Ag, 0.06% Cu and 0.9% Zn within a broader interval of 87.0 meters averaging 1.58 g/t Au, 6.2 g/t Ag, 0.0% Cu and 0.4% Zn. Mineralization is associated with quartz-barite flooding and fracture filling. The typical pyrite-dominant massive sulphides that are commonly observed at Target A are conspicuously absent in this intersection, which suggests that this is a distinct zone of mineralization. Elevated Ag and Zn results with depleted Cu values imply that this zone is most likely not a fault offset of Target A . LP20-167 intersected Target A further down-hole, returning 33.0 meters averaging 4.89 g/t Au, 2.6g/t Ag, 0.4% Cu and 0.0% Zn within a broader interval of 86.0 meters averaging 2.65 g/t Au, 1.8 g/t Ag, 0.3% Cu and 0.0% Zn. Pyrite rich semi-massive sulphide dominates this interval, as expected, at Target A. Both intervals are outside of the optimized pit shell used to constrain the current mineral resource estimate. LP20-169 intersected a new zone of oxide mineralization with 14.0m averaging 2.11 g/t Au, 8.2 g/t Ag, 0.08% Cu and 0.1% Zn. Below this intersection, disseminated sulphide mineralization continued, returning 154.0 meters averaging 0.58 g/t Au, 1.95 g/t Ag, 0.11% Cu and 0.14% Zn starting at a depth of 2.0 meters down hole. This upper interval is intensely oxidized to a depth of 20.0 meters. The lack of pyrite-rich sulphides and presence of quartz and barite floods and fracture filling suggest this zone correlates to the mineralization initially intersected in LP20-167. LP20-169 intersected Target A where initially anticipated, at a depth of 340 meters down hole returning 26.0 meters averaging 0.97 g/t Au, 1.3 g/t Ag, 0,1% Cu and 0.06% Zn. Pyrite rich, net-textured massive sulphide is visually observed within this interval, suggesting that this hole passed beneath the main part of Target A. The Company continues to have four active drills. The first phase drill program at the Montazo regional exploration target has been completed. This diamond drill will be moved back to Candelones to help with the exploration to the east of known mineralization. Future results will be released as they become available. Figure 1.0 – Plan View – Target A, B and E - Candelones Extension Deposit: https://www.globenewswire.com/NewsRoom/AttachmentNg/e702a7d5-9449-4968-b3bf-965bc486a75c Figure 2.0 – Section Looking NW – Target A, B and E - Candelones Extension Deposit: https://www.globenewswire.com/NewsRoom/AttachmentNg/12eb043d-c111-4ca7-b2c7-b44166b17e58 QA/QC Diamond drilling utilizes both HQ and NQ diameter tooling. Holes are established using HQ diameter tooling before reducing to NQ tooling to complete the hole. The core is received at the on-site logging facility where it is, photographed, logged for geotechnical and geological data and subjected to other physical tests including magnetic susceptibility and specific gravity analysis. Samples are identified, recorded, split by wet diamond saw, and half the core is sent for assay with the remaining half stored on site. A minimum sample length of 0.3 meters and a maximum sample length of 1.5 metres is employed with most samples averaging 1.0 meters in length except where geological contacts dictate. Certified standards and blanks are randomly inserted into the sample stream and constitute approximately 5-10% of the sample stream. Samples are shipped to a sample preparation facility in the Dominican Republic operated by Bureau Veritas. Assaying is performed at Bureau Veritas Commodities Canada Ltd.’s laboratory in Vancouver, B.C. Canada. All samples are analyzed for gold using a 50 gram lead collection fire assay fusion with an atomic adsorption finish. In addition, most samples are also assayed using a 36 element multi-acid ICP-ES analysis method. Wes Hanson P.Geo., Chief Operating Officer of Unigold has reviewed and approved the contents of this press release. About Unigold Inc. – Discovering Gold in the Caribbean Unigold is a Canadian based mineral exploration company traded on the TSX Venture Exchange under the symbol UGD, focused primarily on exploring and developing its gold assets in the Dominican Republic. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-looking StatementsCertain statements contained in this document, including statements regarding events and financial trends that may affect our future operating results, financial position and cash flows, may constitute forward-looking statements within the meaning of the federal securities laws. These statements are based on our assumptions and estimates and are subject to risk and uncertainties. You can identify these forward-looking statements by the use of words like “may”, “interpreted”, “strategy”, “expects”, “plans”, “believes”, “will”, “estimates”, “intends”, “projects”, “goals”, “targets”, and other words of similar meaning. You can also identify them by the fact that they do not relate strictly to historical or current facts. We wish to caution you that such statements contained are just predictions or opinions and that actual events or results may differ materially. The forward-looking statements contained in this document are made as of the date hereof and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ materially from those projected in the forward-looking statements. Where applicable, we claim the protection of the safe harbour for forward-looking statements provided by the (United States) Private Securities Litigation Reform Act of 1995. CONTACT: For further information please visit www.unigoldinc.com or contact: Mr. Joseph Hamilton Chairman & CEO jhamilton@unigoldinc.com 416.866.8157